Scope Technologies
Background
In a collaboration between Yrgo and Chalmers Ventures, Maja Saaranen and I got the opportunity to work with the start-up called Envue Technologies. The client wanted to stand out from other companies that act in the same area and wasn't too comfortable with their name—so we created a visual identity including a new name, logo and photos.
Scope’s microscopy technology enables new results in early drug development. By imaging molecules with better sensitivity than competitive methods, researchers can get comprehensive data about protein complexes. This will speed up the long process of compound screening and help the industry in the development of safe pharmaceuticals. They use a microscopic device (nanoscope), software and a nanofluidic chip.
